ABSTRACT
Introduction

26
Photoreceptor (PR) degenerative diseases such as retinitis pigmentosa and macular degeneration are 27 leading causes of presently incurable blindness. The irreversible vision loss in these diseases is ultimately 28 due to the loss of PR cells, which normally transduce visual information into chemical signals that 29 activate the retinal ganglion cell (RGC) layer through a network of neurons in the inner nuclear layer 30 (INL) . Of the various strategies explored for treatment of PR degeneration over the last two decades, 31 including gene therapy and stem cell transplantation, retinal-based prostheses have emerged as the most 32 promising to restore vision in blind patients 1 . The treatment strategy of retinal prostheses is predicated on OFF and ON components is maintained throughout the entire visual system, differential stimulation of 43 these pathways is critical to restoring naturalistic vision to patients with PR degeneration with a retinal 44 prosthesis. In addition, a retinal prosthesis must be able to localize the stimulation ideally to a single cell 45 or a few cells to achieve high spatial specificity, i.e., good visual acuity. Fig. S2a ). An example of this relationship can be seen in Supplementary Fig. S2b identified to provide a sufficiently large representative dataset for meaningful analyses and conclusions.
290
The explanted retinas were placed onto a perforated MEA (pMEA200/30iR-Ti, Multichannel Systems,
291
GmbH) with ganglion cell side towards the electrodes. The MEA chamber was perfused (flow rate 3 292 mL/min) with Ames medium, which was oxygenated with a medical-grade gas mixture of 95% oxygen Instruments, Hamden, CT) were used to both store glutamate chemical and serve as a reference electrode.
312
The pressure port of the micropipette holder was coupled with a pressure injector system (PM-8, Harvard 
